Physician

Kim S Frederickson, MD

According to 2025 Medicare claims, Kim Frederickson, MD (NPI: 1003995291) practices dermatology in the San Rafael, CA market, with the plurality of this provider's patient population coming from Marin, CA. This provider's primary affiliated billing organization is NOVATO DERMATOLOGY ASSOCIATES A MEDICAL CORPORATION (NPI: 1003960063; TIN: 47-0861536) and primary practice location at 94947-4367.

Frederickson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 783 traditional Medicare patients, billed 5,644 HCPCS/CPT codes, and received $364,184 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 834 prescription claims across 337 beneficiaries totaling $40,904 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 1 records totaling $14. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $44,695 to $40,904. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	772	6,167	$317,997
2016	764	6,109	$297,734
2017	829	6,006	$331,702
2018	877	6,206	$337,922
2019	956	6,474	$365,581
2020	781	5,445	$290,555
2021	703	5,034	$292,942
2022	775	5,591	$350,738
2023	805	6,206	$399,700
2024	783	5,644	$364,184

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	226	691	$44,695
2016	262	700	$42,439
2017	288	758	$34,060
2018	335	857	$68,670
2019	377	995	$70,566
2020	327	1,009	$68,426
2021	297	796	$93,790
2022	345	937	$102,425
2023	369	969	$134,716
2024	337	834	$40,904

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	417	572	$115
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	490	644	$106
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	378	604	$81
17000	Destruction of precancer skin growth, 1 growth	392	577	$47
17003	Destruction of precancer skin growth, 2-14 growths	290	1,700	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Clobetasol Propionate	Clobetasol Propionate	45	1,424	$2,036
Metronidazole	Metronidazole	41	1,325	$1,988
Doxycycline Hyclate	Doxycycline Hyclate	33	1,294	$1,796
Ketoconazole	Ketoconazole	132	4,030	$1,665
Fluocinonide	Fluocinonide	43	1,259	$1,543

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$14	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kim S. Frederickson, MD?

Tedicare shows public-source Medicare data for Kim S. Frederickson, MD (NPI 1003995291), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kim S. Frederickson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kim S. Frederickson, MD?

Kim S. Frederickson, MD is linked to NOVATO DERMATOLOGY ASSOCIATES A MEDICAL CORPORATION (billing NPI 1003960063) in the available physician profile data.

Does Kim S. Frederickson, MD have Open Payments data?

Kim S. Frederickson, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.